Gentiva (Formerly Reported as Humana & Kindred at Home)

Provider of home health and hospice services

Based in GA

🤖

AI Overview

With $1.7M in lobbying spend across 26 quarterly filings, Gentiva (Formerly Reported as Humana & Kindred at Home) is a significant lobbying presence. They deploy 12 individual lobbyists

$1.7M
Total Lobbying Spend
26
Quarterly Filings
1
Lobbying Firms Used
12
Individual Lobbyists

Spending by Year

YearLobbying Spend
2020$200K
2021$320K
2022$560K
2023$200K
2024$180K
2025$240K

Lobbying Firms

TARPLIN, DOWNS & YOUNG, LLC

What They Lobby For

  • coverage and reimbursement of home health and hospice services
  • H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201 - Families First Coronavirus Response Act S. 3548 - CARES Act
  • Home health Hospice care Telemedicine
  • H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201 - Families First Coronavirus Response Act S. 3548 - CARES Act H.R. 6800 - The Heroes Act Provider Relief Funds
  • H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201 - Families First Coronavirus Response Act S. 3548 - CARES Act H.R. 6800 - The Heroes Act Provider Relief Funds H.R. 133 - Consolidated Appropriations Act, 2021
  • Home health Hospice care Telemedicine sequester relief and E&M codes/budget neutrality H.R. 133 - Consolidated Appropriations Act, 2021
  • Provider Relief Funds coronavirus response H.R. 1319, American Rescue Plan of 2021
  • Home health Hospice care Telemedicine sequester relief and E&M codes/budget neutrality H.R. 1319, American Rescue Plan of 2021
  • Home health Hospice care Telemedicine sequester relief and E&M codes/budget neutrality H.R. 1319, American Rescue Plan of 2021 implementation HEAT Act
  • Provider Relief Funds coronavirus response H.R. 1319, American Rescue Plan of 2021 implementation

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.